GSA Capital Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
62,625
+39,783
| +174% | +$680K | 0.08% | 415 |
|
|
2025
Q1 | $1.46M | Buy |
+22,842
| New | +$1.46M | 0.13% | 179 |
|
|
2024
Q3 | – | Sell |
-2,896
| Closed | -$458K | – | 1988 |
|
|
2024
Q2 | $458K | Sell |
2,896
-2,156
| -43% | -$341K | 0.03% | 1021 |
|
|
2024
Q1 | $654K | Sell |
5,052
-1,589
| -24% | -$206K | 0.05% | 723 |
|
|
2023
Q4 | $640K | Sell |
6,641
-174
| -3% | -$16.8K | 0.05% | 631 |
|
|
2023
Q3 | $826K | Buy |
+6,815
| New | +$826K | 0.07% | 508 |
|
|
2023
Q1 | – | Sell |
-6,134
| Closed | -$795K | – | 1912 |
|
|
2022
Q4 | $795K | Sell |
6,134
-1,136
| -16% | -$147K | 0.1% | 329 |
|
|
2022
Q3 | $804K | Buy |
7,270
+2,653
| +57% | +$293K | 0.11% | 259 |
|
|
2022
Q2 | $346K | Sell |
4,617
-1,215
| -21% | -$91.1K | 0.05% | 735 |
|
|
2022
Q1 | $456K | Sell |
5,832
-2,205
| -27% | -$172K | 0.06% | 599 |
|
|
2021
Q4 | $724K | Buy |
+8,037
| New | +$724K | 0.09% | 369 |
|
|
2021
Q3 | – | Sell |
-3,403
| Closed | -$265K | – | 1752 |
|
|
2021
Q2 | $265K | Buy |
+3,403
| New | +$265K | 0.03% | 1023 |
|
|
2021
Q1 | – | Sell |
-1,520
| Closed | -$259K | – | 1477 |
|
|
2020
Q4 | $259K | Sell |
1,520
-1,624
| -52% | -$277K | 0.04% | 824 |
|
|
2020
Q3 | $442K | Buy |
+3,144
| New | +$442K | 0.07% | 470 |
|
|
2019
Q4 | – | Sell |
-6,961
| Closed | -$524K | – | 1712 |
|
|
2019
Q3 | $524K | Buy |
+6,961
| New | +$524K | 0.07% | 522 |
|
|
2019
Q2 | – | Sell |
-2,597
| Closed | -$310K | – | 1709 |
|
|
2019
Q1 | $310K | Buy |
+2,597
| New | +$310K | 0.03% | 973 |
|
|
2015
Q4 | – | Sell |
-6,245
| Closed | -$201K | – | 1952 |
|
|
2015
Q3 | $201K | Buy |
+6,245
| New | +$201K | 0.01% | 1575 |
|